The European Commission authorizes the use of the protein-based Novavax COVID-19 vaccine after the European Medicines Agency recommends the use of the vaccine, becoming the fifth vaccine to be approved by the European Union.
The European Commission authorizes the use of the Novavax COVID-19 vaccine after the European Medicines Agency recommended the use of the vaccine, becoming the fifth vaccine to be approvedforuse by the European Union.